Independent information. England-wide.Public data. Clear sources.

NCT07007065

Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)

Registered research study with 6 identifiable England locations. See source dates, location-specific recruitment and the original study record.

Study facts

Conditions recorded
Neovascular Age-related Macular Degeneration
Lead sponsor
AbbVie
Study type
Interventional
Overall status
Recruiting · this can differ by location
Age range in the record
50 Years to Not specified
Sex eligibility field
All
Healthy volunteers accepted
No, according to the record
Phase
Phase3
Study record last updated
8 September 2026
Study team last verified status
2026-09

These fields are a starting point. Eligibility can include diagnosis, treatment history and other criteria shown only in the complete source record. A registry entry does not establish treatment effectiveness.

England study locations

A location is reproduced as named in the study record. A source map point can represent a town; it is not used here as a hospital entrance or to identify a care provider.

Location in the sourceLocal recruitment statusGeographic connection
Gloucestershire Royal Hospital /ID# 276072

Gloucester · GL1 3NN

RecruitingCare in Gloucester

England postcode

Moorfields Eye Hospital /ID# 267227

London · EC1V 2PD

RecruitingCare in Islington

England postcode

The Retina Clinic London /ID# 266156

London · W1G 7LB

RecruitingCare in Westminster

England postcode

Liverpool University Hospitals NHS Foundation Trust /ID# 265854

Liverpool · L9 7AL

RecruitingCare in Liverpool

England postcode

Bristol Eye Hospital /ID# 266155

Bristol · BS1 2LX

RecruitingCare in Bristol

England postcode

Sunderland Royal Hospital /ID# 266664

Sunderland · SR4 7TN

RecruitingCare in Sunderland

England postcode

Questions for the research team

  • Is this exact location currently enrolling participants, and do my circumstances meet the full criteria?
  • What visits, tests, possible risks and follow-up would participation involve?
  • Are travel costs or accessibility arrangements available?
  • How would participation affect my usual care, and what happens if I withdraw?

Source: ClinicalTrials.gov, a United States Government database. Contains OS data © Crown copyright and database right 2026. Contains National Statistics data © Crown copyright and database right 2024; ONS country boundaries (December 2024).

Source processed: 2026-09-10 09:00:04 UTC. Retrieved: 10 September 2026. ClinicalTrials.gov terms.

How we selected and connected these records

Selected registered studies with an overall status of Recruiting or Not yet recruiting and at least one England location established by postcode, recorded nation, or source coordinates within the ONS December 2024 boundary. Retained structured fields; omitted descriptions, eligibility text, contacts and non-England locations. Deduplicated identical locations. Linked local care areas only by exact postcode geography. Location points are used for nation filtering, not directions or facility matching.